Title:
The compound tablet containing sustained-release Metformin and immediate-release HMG-CoA reducing enzyme inhibitor
Document Type and Number:
Japanese Patent JP6157740
Kind Code:
B2
Abstract:
The present invention relates to a combination formulation containing metformin for treating non-insulin-dependent diabetes and an HMG-CoA reductase inhibitor for treating dyslipidemia. The present invention provides a combination formulation and a method for preparing the combination formulation, wherein the combination formulation contains metformin and an HMG-CoA reductase inhibitor, and has effectively improved stability by blocking physical and chemical reactions between the active ingredients while securing the stable release of respective active ingredients.
More Like This:
Inventors:
Canquiman
Park Young Jun
Park Jun Hong
Ijiun
Yun Sukki
Kim Yoo Jung
Otaku
Chotechun
Park Young Jun
Park Jun Hong
Ijiun
Yun Sukki
Kim Yoo Jung
Otaku
Chotechun
Application Number:
JP2016529716A
Publication Date:
July 05, 2017
Filing Date:
July 25, 2014
Export Citation:
Assignee:
CJ HEALTHCARE CORPORATION
International Classes:
A61K31/155; A61K9/22; A61K9/32; A61K31/22; A61K31/366; A61K31/40; A61K31/404; A61K31/47; A61K31/505; A61K47/10; A61K47/14; A61K47/32; A61K47/36; A61K47/38; A61K47/44; A61P3/06; A61P3/10; A61P43/00
Domestic Patent References:
| JP2013516409A | ||||
| JP2009191034A | ||||
| JP62030709A | ||||
| JP2013526516A |
Foreign References:
| EP0177000A1 | ||||
| KR100791844B1 |
Attorney, Agent or Firm:
Patent Business Corporation Saegusa International Patent Office